Your browser doesn't support javascript.
loading
Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period.
Lazor-Blanchet, C; Zygoura, P; Dafni, U; Lamoth, F; Tsourti, Z; Lobritz, M A; Regina, J; Grandbastien, B; Fenwick, C; Pantaleo, G; Calandra, T; Meylan, S.
Afiliação
  • Lazor-Blanchet C; Occupational health unit, Service of Hospital Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland.
  • Zygoura P; Frontier Science Foundation-Hellas, Athens, Greece.
  • Dafni U; Frontier Science Foundation-Hellas, Athens, Greece; National and Kapodistrian University of Athens, Athens, Greece.
  • Lamoth F; Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; Institute of Microbiology, Lausanne University Hospital and University, Lausanne, Switzerland.
  • Tsourti Z; Frontier Science Foundation-Hellas, Athens, Greece.
  • Lobritz MA; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
  • Regina J; Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Grandbastien B; Service of Hospital Preventive Medicine, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Fenwick C; Immunology Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Pantaleo G; Immunology Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Calandra T; Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Meylan S; Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Electronic address: Sylvain.meylan@chuv.ch.
J Infect ; 84(5): 722-746, 2022 05.
Article em En | MEDLINE | ID: mdl-35134464
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article